Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Save to My Library
Look up keyword
Like this
66Activity
0 of .
Results for:
No results containing your search query
P. 1
SWOT N PORTER 5 forces - indian pahrma

SWOT N PORTER 5 forces - indian pahrma

Ratings:

4.74

(23)
|Views: 10,454 |Likes:
Published by bhupendraa

More info:

Published by: bhupendraa on Jan 11, 2009
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as DOC or read online from Scribd
See more
See less

06/11/2013

 
Project-Report
SWOT Analysis & Porter’s five force model analysisof 
The Indian pharmaceutical industry
Introduction
 
 ______________________________ 
 
“The Indian pharmaceutical industry is a success story providingemployment for millions and ensuring that essential drugs at affordable prices are available to the vast population of this sub-continent.” 
 
- Richard Gerster
The
Indian Pharmaceutical Industry
today is in the front rank of India’s science-basedindustries with wide ranging capabilities in the complex field of drug manufacture andtechnology. A highly organized sector, the Indian Pharma Industry is estimated to beworth $ 4.5 billion, growing at about 8 to 9 percent annually. It ranks very high in thethird world, in terms of technology, quality and range of medicines manufactured. Fromsimple headache pills to sophisticated antibiotics and complex cardiac compounds,almost every type of medicine is now made indigenously.Playing a key role in promoting and sustaining development in the vital field of medicines,
Indian Pharma Industry
boasts of quality producers and many unitsapproved by regulatory authorities in USA and UK. International companies associatedwith this sector have stimulated, assisted and spearheaded this dynamic development inthe past 53 years and helped to put India on the pharmaceutical map of the world.The Indian Pharmaceutical sector is highly fragmented with more than 20,000 registeredunits. It has expanded drastically in the last two decades. The leading 250 pharmaceuticalcompanies control 70% of the market with market leader holding nearly 7% of the marketshare. It is an extremely fragmented market with severe price competition andgovernment price control.The pharmaceutical industry in India meets around 70% of the country's demand for bulk drugs, drug intermediates, pharmaceutical formulations, chemicals, tablets, capsules,orals and injectibles. There are about 250 large units and about 8000 Small Scale Units,which form the core of the pharmaceutical industry in India (including 5 Central PublicSector Units). These units produce the complete range of pharmaceutical formulations,i.e., medicines ready for consumption by patients and about 350 bulk drugs, i.e.,chemicals having therapeutic value and used for production of pharmaceuticalformulations.2
 
Following the de-licensing of the pharmaceutical industry, industrial licensing for most of the drugs and pharmaceutical products has been done away with. Manufacturers are freeto produce any drug duly approved by the Drug Control Authority. Technologicallystrong and totally self-reliant, the pharmaceutical industry in India has low costs of  production, low R&D costs, innovative scientific manpower, strength of nationallaboratories and an increasing balance of trade. The Pharmaceutical Industry, with its richscientific talents and research capabilities, supported by Intellectual Property Protectionregime is well set to take on the international market.The industry has achieved global recognition as a
"low cost producer of quality bulk drugs and formulations"
.The phenomenal progress made by the industry over the years is depicted in Tables 1 &2.
Table 1.TEMPORAL PROGRESS OF THE PHARMA INDUSTRYYearStatus
1950sFormulationsMostly imported MNC dominance1960sFormulationsDomestic endeavour on imported bulk drugs1970sFormulationsBulk drugsSome imports.Indigenous manufacture by domestic companies1980sFormulationsBulk drugsMarginal imports (<5%)Significant indigenous manufacture (based on domesticR&D)1990sFormulationsBulk drugsSignificant exports, minimal imports (< 2%)Self reliant (exports > imports)
Table 2. GROWTH OF PHARMA INDUSTRY(Rs. in Million)
 
INDICATORS
 
1965-66 1994-95 1997-98Compoundgrowth over 94-
3

Activity (66)

You've already reviewed this. Edit your review.
1 hundred reads
1 thousand reads
Mubashir Ali liked this
Mary Zavalska liked this
Jalpa Pithava added this note
plz send it on jpithava@yahoo.in
Jalpa Pithava added this note
plz allow me to download it or send me at jpithava@yahoo.in
Tarun Soni liked this
Puneet Rastogi liked this
Devansh Parikh liked this
Manish Sharma liked this

You're Reading a Free Preview

Download
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->